Ads
related to: reaction during or after infusion pump therapy for atrial fibrillation treatment- Should I See a Heart Doc
Talk to your doc about your heart
and learn what to ask
- Patient Testimonials
Hear from our patients
about their Ohio State experience
- Prepare For Your Visit
What to bring to your visit
plus heart & vascular resources
- Find a Doctor
Meet with our experts to diagnose
your symptoms and receive treatment
- Should I See a Heart Doc
Search results
Results from the WOW.Com Content Network
Common adverse drug reactions (≥1% of patients) associated with levosimendan therapy include: headache, hypotension, arrhythmias (atrial fibrillation, extrasystoles, Atrial tachycardia, ventricular tachycardia), myocardial ischaemia, hypokalaemia and/or nausea (Rossi, 2006).
In transfusion medicine, transfusion-associated circulatory overload (aka TACO) is a transfusion reaction (an adverse effect of blood transfusion) resulting in signs or symptoms of excess fluid in the circulatory system (hypervolemia) within 12 hours after transfusion. [2]
Nurse preparing an infusion. In medicine, infusion therapy deals with all aspects of fluid and medication infusion, via intravenous or subcutaneous application. A special infusion pump can be used for this purpose. [1] A fenestrated catheter is frequently inserted into the localized area to be treated.
After the procedure, the patient is monitored to ensure stability of the sinus rhythm. Synchronized electrical cardioversion is used to treat hemodynamically unstable supraventricular (or narrow complex) tachycardias, including atrial fibrillation and atrial flutter.
[13] [14] [15] In some pulsatile pumps (that use compressed air as an energy source [16]), the volume occupied by blood varies during the pumping cycle. If the pump is contained inside the body then a vent tube to the outside air is required. Continuous-flow VADs are smaller and have proven to be more durable than pulsatile VADs. [17]
Recurrence of atrial fibrillation within three months of an ablation is seen in most patients, but many of those patients become free of atrial fibrillation in the long term. [17] For this reason the first three months after an ablation are described as the "blanking period," during which no further intervention is to be attempted. [17]
The left atrial appendage is a pouch-like structure located in the upper part of the left atrium. [1] Left atrial appendage occlusion (LAAO) is an alternative therapy to oral anticoagulation in a certain subset of patients with atrial fibrillation. Atrial fibrillation is characterized by an irregular and uncoordinated pumping function of the atria.
Milrinone is a commonly used therapy for severe pulmonary arterial hypertension (PAH), [14] often in combination with other medications such as sildenafil. [15] Targeting PDE3 with optimal doses and timing, milrinone prevents allergic inflammation in HDM-driven models of allergic airway inflammation.
Ads
related to: reaction during or after infusion pump therapy for atrial fibrillation treatment